Showing results (31-40 of 89) with videos related to
Sort By:
Pageof 9
Best Practice & Research. Clinical Rheumatology|December 6, 2011
B-cell therapies in established rheumatoid arthritisMaria J Leandro, Elena Becerra-FernandezClinical Rheumatology|October 26, 2010
Tuberculosis and anti-TNF treatment: experience of a central London hospitalSatveer Mankia, James E Peters, Swan Kang, et al.Trials|July 18, 2020
Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis planPatrick Muller, Kashfia Chowdhury, Caroline Gordon, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
Natural IgM is required for suppression of inflammatory arthritis by apoptotic cellsClare A Notley, Mark A Brown, Graham P Wright, et al.European Journal of Immunology|December 15, 2004
Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitroPierre Quartier, Paul K Potter, Michael R Ehrenstein, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 miceSarah Lawman, Claudia Mauri, Elizabeth C Jury, et al.Rheumatology (Oxford, England)|May 4, 2021
The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volumeMuhammad Ruhul Amin Shipa, Su-Ann Yeoh, Andrew Embleton-Thirsk, et al.Iscience|September 2, 2021
Regulatory T cells enhance Th17 migration in psoriatic arthritis which is reversed by anti-TNFDao X Nguyen, Helen M Baldwin, Amara N Ezeonyeji, et al.Scientific Reports|February 8, 2017
DNA methylation governs the dynamic regulation of inflammation by apoptotic cells during efferocytosisClare A Notley, Christine K Jordan, Jenny L McGovern, et al.Rheumatology (Oxford, England)|February 17, 2012
B-cell numbers and phenotype at clinical relapse following rituximab therapy differ in SLE patients according to anti-dsDNA antibody levelsMark N Lazarus, Tabitha Turner-Stokes, Konstantia-Maria Chavele, et al.Pageof 9